Related references
Note: Only part of the references are listed.Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Mayda Gursel et al.
ALLERGY (2020)
Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?
Joseph Kattan et al.
IMMUNOTHERAPY (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Silvia Vivarelli et al.
CANCERS (2020)
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies
Denis Migliorini et al.
ONCOIMMUNOLOGY (2017)
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury
Christopher R. Heery et al.
CLINICAL CANCER RESEARCH (2017)
Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas An Immunohistochemical Study of 5229 Cases
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
Yong Feng et al.
ONCOTARGET (2015)
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Christopher R. Heery et al.
CANCER IMMUNOLOGY RESEARCH (2015)
PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Dimitrios Mathios et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)
Renee N Donahue et al.
Journal for ImmunoTherapy of Cancer (2014)
Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
Henning Lauterbach et al.
PLOS ONE (2010)
Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes
XF Shen et al.
JOURNAL OF IMMUNOLOGY (2002)
Isolated cardiac metastasis from sacral chordoma
Y Oda et al.
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2000)
Share Paper
